Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Financing Activities (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Cash from Financing Activities data on record, last reported at $2.4 million in Q1 2013.

  • For Q1 2013, Cash from Financing Activities rose 1952.27% year-over-year to $2.4 million; the TTM value through Mar 2013 reached $3.8 million, up 8.73%, while the annual FY2025 figure was $3.0 million, 80.79% up from the prior year.
  • Cash from Financing Activities reached $2.4 million in Q1 2013 per SNOA's latest filing, up from -$569000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $2.6 million in Q4 2011 and bottomed at -$569000.0 in Q4 2012.
  • Average Cash from Financing Activities over 4 years is $823583.3, with a median of $444500.0 recorded in 2010.
  • Peak YoY movement for Cash from Financing Activities: tumbled 342.86% in 2011, then skyrocketed 1952.27% in 2013.
  • A 4-year view of Cash from Financing Activities shows it stood at $959000.0 in 2010, then skyrocketed by 174.45% to $2.6 million in 2011, then crashed by 121.62% to -$569000.0 in 2012, then surged by 529.7% to $2.4 million in 2013.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $2.4 million in Q1 2013, -$569000.0 in Q4 2012, and -$491000.0 in Q3 2012.